Efficacy and Adverse Effects of Sofosbuvir plus Daclatasvir Therapy in Chronic HCV Patients in Sharkia Governorate, Egypt

Faculty Medicine Year: 2018
Type of Publication: ZU Hosted Pages: 8
Authors:
Abeer Hessien Abdelkader Abdelaziz
Journal: afroegyptian journal of infectious and endemic diseases Zagazig University, Faculty of Medicine, Hepatology, Gastroenterology, Infectious and Tropical Diseases Department Volume: 8
Keywords : Efficacy , Adverse Effects , Sofosbuvir plus Daclatasvir Therapy    
Abstract:
Daclatasvir plus sofosbuvir with or without ribavirin for 12 or 24 weeks is highly effective in treatment of naïve or experienced Egyptian HCV patients in Sharkia governorate. This combination is well tolerated in both cirrhotic and noncirrhotic patients with mild adverse effects.
    
     
 
       

Author Related Publications

  • Abeer Hessien Abdelkader Abdelaziz, "osteoporosis in chronic hepatitis c", Afro-Egyptian Journal of Infectious and Endemic Diseases, 2014 More
  • Abeer Hessien Abdelkader Abdelaziz, "The relative risk of clinically relevant cholelithiasis among glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus, real-world study", BMC Part of Springer Nature, 2024 More
  • Abeer Hessien Abdelkader Abdelaziz, "IL-1α and TGF-β1 as non-Invasive Liver Fibrosis Markers of Chronic Liver Injury among Chronic Liver Diseases Patients in Sharkia Governorate, Egypt", Zagazig University, Faculty of Medicine, Hepatology, Gastroenterology, Infectious and Tropical Diseases Department, 2020 More
  • Abeer Hessien Abdelkader Abdelaziz, "Evaluation of the Prognostic Role of Leptin and Cyclin D1 Expression in Colorectal Cancer", Shiraz University of Medical Sciences, 2024 More
  • Abeer Hessien Abdelkader Abdelaziz, "The Role of Mean Platelet Volume in the Diagnosis of Spontaneous Bacterial Peritonitis: A Cross Sectional Study", Zagazig University, Faculty of Medicine, Hepatology, Gastroenterology, Infectious and Tropical Diseases Department, 2019 More

Department Related Publications

  • Taghreed Mohamed Abdallah Mahmud, "MELD Score as a Predictor of Treatment Response of ‘Difficult to Treat’ Chronic HCV Patients", Zagazig University. Faculty of Medicine. Endemic and Tropical Medicine Department http://mis.zu.edu.eg/ajied/home.aspx, 2019 More
  • Halle Ismail Mouhammed, "Ghrelin: Can It Affect The Nutrition And Morbidity In Cirrhotic Patients? الجريلين: هل يستطيع أن يؤثر على التغذية والنسبة المرضية فى مرضى التشمع الكبدى؟", المجلة العلمية لكلية طب بنات الأزهر, 2007 More
  • Noha Elsyd AbdulSattar, "Frequency of Hepatocellular Carcinoma among Cirrhotic Patients with Hepatic Focal Lesion(s) and Low Serum Level of Alpha Fetoprotein تواتر سرطان الخلايا الكبدية بين مرضى التشمع الكبدي الذين لديهم بؤر كبدية وانخفاض مستوى الألفا فيتوبروتين", The Medical Journal of Cairo University, 2017 More
  • Mohamed Ahmed Mohamed Suleiman Saraya, "Evaluation of leptin, interleukin-1 beta and tumor necrosis factor alpha in serum of malaria patients as prognostic markers of treatment outcome تقييم مستوي هرمون اللبتين والانترلوكين -1 وعامل النخر الورمي الفا في مصل دم مرضي الملاريا كعلا", Asian Pacific Journal of Tropical Biomedicine, 2014 More
  • Ahmed Lotfy Mohamed Zaki Sharf, "Evaluation of Thyroid Functions in Cirrhotic Patients with Refractory Ascites", Zagazig University. Faculty of Medicine. Endemic and Tropical Medicine Department, 2022 More
Tweet